Benchmark Reiterates Buy on Analogic

Benchmark is out with its report today on Analogic

, reiterating Buy. In its report, Benchmark writes, "Increase our FY12 estimates and reiterate our BUY. We increase our FY12 revenue estimate by $15 million to $508 million, representing 7% growth y/y. We increase our EPS by $0.12 to $2.58, which reflects 11% y/y growth based on an 8.8% operating margin (Non-GAAP). We continue to like Analogic for its market and technology leadership in medical imaging, mammography, specialized ultrasound, and aviation security and for potential upside to consensus estimates in FY12." Benchmark maintains a $60 PT on ALOG. Shares of ALOG closed Tuesday at $47.87, up 7.01% from Monday's close.